Idorsia launches QUVIVIQ in Switzerland a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning - Marketscreener.com
| ATS Stock | EUR 13.32 0.43 3.13% |
Under 61% of AT S's investor base is looking to short. The analysis of current outlook of investing in AT S Austria suggests that many traders are alarmed regarding AT S's prospects. AT S's investing sentiment shows overall attitude of investors towards AT S Austria.
ATS |
Idorsia launches QUVIVIQ in Switzerland a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning Marketscreener.com
Read at news.google.com
 |
AT S Fundamental Analysis
We analyze AT S's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AT S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AT S based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
AT S is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
AT S Austria Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AT S stock to make a market-neutral strategy. Peer analysis of AT S could also be used in its relative valuation, which is a method of valuing AT S by comparing valuation metrics with similar companies.
Peers
AT S Related Equities
| ANDR | Andritz AG | 0.33 |
| ||
| LNZ | Lenzing Aktiengesellscha | 1.01 |
| ||
| OMV | OMV Aktiengesellscha | 1.14 |
| ||
| WIE | Wienerberger | 1.51 |
| ||
| VOE | Voestalpine | 3.13 |
|
Complementary Tools for ATS Stock analysis
When running AT S's price analysis, check to measure AT S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AT S is operating at the current time. Most of AT S's value examination focuses on studying past and present price action to predict the probability of AT S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AT S's price. Additionally, you may evaluate how the addition of AT S to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |